Immunoscintigraphy of CEA-Producing Tumors with Special Emphasis on the Use of Mab Fragments and ECT

  • A. Bischof-Delaloye
  • B. Delaloye
  • F. Buchegger
  • V. von Fliedner
  • J.-P. Mach

Abstract

The first reports that carcinoma could be detected in patients by external scanning following injection of purified I-131-labeled anti-CEA antibodies were made by Goldenberg et al. [1, 2]. They claimed that almost all the CEA-producing tumors could be detected by this method and that there were no false-positive results. However, our experience with highly purified goat anti-CEA antibodies [3] and the same blood pool subtraction technique used by Goldenberg was that only 42% of CEA-producing tumors (22 out of 53 tested) could be detected by this method [4]. Furthermore, we found that in several patients the labeled anti-CEA antibodies localized nonspecifically in the reticuloendothelium, particularly in the liver. Despite the use of the subtraction technique, it was difficult to differentiate this nonspecific uptake from the specific uptake in liver metastases. The discrepancy in the results obtained by the group of Goldenberg and our own is unlikely to be due to a difference in the quality of the anti-CEA antibodies used, since a direct measurement of the radioactivity in tumors resected after injection showed that our antibodies were capable of excellent tumor localization [4]. Furthermore, in a few patients scheduled for tumor resection, we injected simultaneously 1 mg goat anti-CEA antibodies labeled with 1 mCi I-131 and 1 mg control normal goat IgG labeled with 0.2 mCi I-125. With this paired labeled method adapted to the patient situation, we demonstrated that the antibody uptake was four times higher than that of control normal IgG [4].

Keywords

Albumin Adenocarcinoma Radionuclide Prednisolone Pertechnetate 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Goldenberg DM, Deland F, Kim E et al. (1978) Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med 298:1384–1388PubMedCrossRefGoogle Scholar
  2. 2.
    Goldenberg DM, Kim E, Bennett SJ et al. (1983) Carcinoembryonic antigen radioimmunodetection in the evaluation of colorectal cancer and in the detection of occult neoplasms. Gastroenterology 84:524–532PubMedGoogle Scholar
  3. 3.
    Mach JP, Carrel S, Merenda C et al. (1974) In vivo localization of radiolabeled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature 248:704–706PubMedCrossRefGoogle Scholar
  4. 4.
    Mach JP, Carrel S, Forni M et al. (1980) Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma. N Engl J Med 303:5–10PubMedCrossRefGoogle Scholar
  5. 5.
    Mach JP, Buchegger F, Forni M et al. (1981) Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning tomoscintigraphy. Immunol Today 2:239–249CrossRefGoogle Scholar
  6. 6.
    Berche C, Mach JP, Lumbroso JD et al. (1982) Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Br Med J 285:1447–1451CrossRefGoogle Scholar
  7. 7.
    Epenetos AA, Mather S, Granowska M et al. (1982) Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast and gastrointestinal tumours. Lancet 8306:999–1005CrossRefGoogle Scholar
  8. 8.
    Haskell CM, Buchegger F, Schreyer M et al. (1983) Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphy. Cancer Res 43:3857–3864PubMedGoogle Scholar
  9. 9.
    Buchegger F, Haskell CM, Schreyer M et al. (1983) Radiolabeled fragments of monoclonal anti-CEA antibodies for localization of human colon carcinoma grafted into nude mice. J Exp Med 158:413–427PubMedCrossRefGoogle Scholar
  10. 10.
    Ott J, Grey LJ, Zivanovic MA et al. (1983) The limitations of the dual radionuclide subtraction technique for the external detection of tumours by radioiodine-labelled antibodies. Br J Radiol 56:101–108PubMedCrossRefGoogle Scholar
  11. 11.
    Halpem SE, Buchegger F, Schreyer M et al. (1984) Effect of size of radiolabeled antibody and fragments on tumor uptake and distribution in nephrectomized mice. J Nucl Med 25:112Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • A. Bischof-Delaloye
    • 1
  • B. Delaloye
  • F. Buchegger
  • V. von Fliedner
  • J.-P. Mach
  1. 1.Division autonome de médecine nucleáireCentre Hospitalier Universitaire VaudoisLausanneSwitzerland

Personalised recommendations